ATM/ATR-related checkpoint signals mediate arsenite-induced G2/M arrest in primary aortic endothelial cells

Archives of Toxicology

Volumn 80, Issue 12, 2006, Pages 804-810

  Tsou, Tsui Chun ^a   Tsai, Feng Yuan ^a   Yeh, Szu Ching ^a   Chang, Louis W ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Arsenite; ATM ATR; Cdc25B; Cdc25C; Mitosis; P53; Securin

Indexed keywords

ARSENIC TRIOXIDE; ATM PROTEIN; ATR PROTEIN; CAFFEINE; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 25B; CELL CYCLE PROTEIN 25C; DNA; PROTEIN P53; SECURIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; ENDOTHELIUM CELL; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; ARSENITES; CAFFEINE; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; G2 PHASE; MITOSIS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; SODIUM COMPOUNDS; SWINE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; SUIDAE;

EID: 33751518046     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-006-0110-4     Document Type: Article

References (35)

1. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177-2196
2. Bartek J, Lukas J (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 13:738-747
3. Bau DT, Wang TS, Chung CH, Wang AS, Jan KY (2002) Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. Environ Health Perspect 110(Suppl. 5):753-756
4. Blasina A, Price BD, Turenne GA, McGowan CH (1999) Caffeine inhibits the checkpoint kinase ATM. Curr Biol 9:1135-1138
5. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL, Tai TY (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25:53-60
6. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY (1996) Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 16:504-510
7. Chen F, Zhang Z, Bower J, Lu Y, Leonard SS, Ding M, Castranova V, Piwnica-Worms H, Shi X (2002) Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 99:1990-1995
8. Chen SC, Tsai MH, Wang HJ, Yu HS, Chang LW (2004) Vascular permeability alterations induced by arsenic. Hum Exp Toxicol 23:1-7
9. Cheng Y, Chang LW, Tsou TC (2006) Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Arch Toxicol 80:313-321
10. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ (1997) Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717-1723
11. Engel RR, Smith AH (1994) Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health 49:418-427
12. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH (1994) Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 16:184-209
13. Hagting A, Den Elzen N, Vodermaier HC, Waizenegger IC, Peters JM, Pines J (2002) Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1. J Cell Biol 157:1125-1137
14. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316-323
15. Kohn KW (1999) Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol Biol Cell 10:2703-2734
16. Li X, Ding X, Adrian TE (2003) Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression. Pancreas 27:174-179
17. Li X, Ding X, Adrian TE (2004) Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells. Cancer Invest 22:389-400
18. Melo J, Toczyski D (2002) A unified view of the DNA-damage checkpoint. Curr Opin Cell Biol 14:237-245
19. Michael D, Oren M (2003) The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13:49-58
20. Nasmyth K, Peters JM, Uhlmann F (2000) Splitting the chromosome: cutting the ties that bind sister chromatids. Science 288:1379-1385
21. Nilsson I, Hoffmann I (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4:107-114
22. Piwnica-Worms H (1999) Cell cycle. Fools rush in. Nature 401:535, 537
23. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
24. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59:4375-4382
25. Seol JG, Park WH, Kim ES, Jung CW, Hyun JM, Kim BK, Lee YY (1999) Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem Biophys Res Commun 265:400-404
26. Tseng CH (2002) An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 53:529-537
27. Tseng CH, Tai TY, Chong CK, Tseng CP, Lai MS, Lin BJ, Chiou HY, Hsueh YM, Hsu KH, Chen CJ (2000) Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis- hyperendemic villages in Taiwan. Environ Health Perspect 108:847-851
28. Tsou TC, Tsai FY, Wu MC, Chang LW (2003) The protective role of NF-kappaB and AP-1 in arsenite-induced apoptosis in aortic endothelial cells. Toxicol Appl Pharmacol 191:177-187
29. Tsou TC, Yeh SC, Tsai FY, Chang LW (2004) The protective role of intracellular GSH status in the arsenite-induced vascular endothelial dysfunction. Chem Res Toxicol 17:208-217
30. Tsou TC, Tsai FY, Hsieh YW, Li LA, Yeh SC, Chang LW (2005a) Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase. Toxicol Appl Pharmacol 208:277-284
31. Tsou TC, Yeh SC, Tsai EM, Tsai FY, Chao HR, Chang LW (2005b) Arsenite enhances tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1. Toxicol Appl Pharmacol 209:10-18
32. Wang H, Liu D, Wang Y, Qin J, Elledge SJ (2001) Pds1 phosphorylation in response to DNA damage is essential for its DNA damage checkpoint function. Genes Dev 15:1361-1372
33. Yih LH, Lee TC (2000) Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res 60:6346-6352
34. 2 checkpoint activation in CGL-2 cells. Carcinogenesis 26:53-63
35. Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, Takeshita K, Takeshita A, Ohno R (1998) The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12:1383-1391